 CCR2 is highly expressed by thymic pDC and Sirpα + DC  CCR2 is expressed by pDC and cDC in the periphery  CCR2 but not CCL2 is involved in pDC homeostasis  Lack of CCR2 or CCL2 does not affect pDC migration within the thymus ABSTRACT Thymic dendritic cells (DC) play a role in central tolerance. Three thymic DC subtypes have been described: plasmacytoid DC (pDC) and two conventional DC (cDC), CD8α + Sirpα -DC and Sirpα + CD8α -cDC. Both pDC and Sirpα + cDC can take up antigen in periphery and migrate into the thymus in response to chemokine signaling via CCR9 and CCR2 respectively. CCL2 is a major ligand for CCR2 and we previously showed that it was constitutively expressed in thymus, and that mice overexpressing CCL2 in thymus had reduced numbers of autoreactive T cells but elevated numbers of pDC. We have here investigated the role of CCL2-CCR2 axis in thymic pDC migration.
Introduction
Thymic dendritic cells (DC) are involved in both negative selection and induction of regulatory T cells [1] [2] [3] [4] [5] [6] [7] . Three thymic DC subtypes have been described: plasmacytoid DC (pDC) and two conventional DC (cDC), which can be distinguished by their expression of CD8α and Sirpα as CD8α + Sirpα -DC and Sirpα + CD8α -cDC [8] . Both pDC [9] and Sirpα + DC [10] play a role in deletion of autoreactive T cells. DC, including CD8α DC and Sirpα + DC have also been shown to play a role in induction of regulatory T cells [1, 5, 7, 11, 12] . Thymic DC can present self-antigens acquired in the thymus or in the periphery. In the thymus, they can acquire these from medullary thymic epithelial cells [6] , and CD8α DC were shown to present self-peptides produced by mTEC to mediate regulatory T cell selection [5] . DC have the ability to migrate into the thymus [2] , and both pDC [9, 13] and Sirpα + DC [10, 13] have been shown to present self-antigens that were taken up and transported from the periphery to the thymus. DC migration is mediated by chemokines, small secreted proteins known to regulate the migration of immune cells (see review [14] ). The chemokine XCL1 contributes to the medullary accumulation of thymic DCs [11] . Thymic DC can express several chemokine receptors [8, 11, 15] including CCR9 and CCR2 which have been shown to recruit pDC [9] and Sirpα + DC [10] respectively from the periphery. CCL2 is a major ligand for CCR2 and we previously showed that it was constitutively expressed in thymus by endothelial cells, and by cortical and medullary thymic epithelial cells [16] . We also showed that mice overexpressing CCL2 in thymus had reduced numbers of autoreactive T cells and elevated numbers of pDC. We have thus investigated the role of the CCL2-CCR2 axis in steady-state thymic pDC migration.
Results show that CCR2 is expressed at a high level by pDC and by some thymic progenitors, but not those suggested to give rise to pDC. We also show that the frequency of pDC is decreased in thymus, spleen and inguinal lymph nodes in mice lacking CCR2, but not in mice lacking CCL2. Deficiency in CCL2 or CCR2 does not affect the migration of pDC within the thymus. Based on these results we propose that CCR2 is involved in pDC homeostasis.
MATERIALS AND METHODS

Mice
Female C57BL/6j bom (B6) mice were obtained from Taconic Europe A/S. Female CCL2-deficient mice [17] as well as CCR2-red fluorescent protein (RFP)/RFP and CCR2 RFP/+ mice [18] were obtained from The Jackson Laboratory. Colonies of these mice were maintained in the Biomedical Laboratory, University of Southern Denmark (Odense). All experiments were approved by the Danish Animal Experiments Inspectorate (approval number 2014-15-0201-00369).
2.2. Cell preparation and flow cytometry for pDC study Ten-week old CCR2 RFP/+ female mice were used for the analysis of CCR2 expression by DC subtypes. Six to eight-week old B6, CCL2 and CCR2 RFP/RFP females were used to investigate the proportions of pDC in the different lymphoid tissues and the absolute number of thymic pDC. Mice were anesthetized with pentobarbital (Mebumal®, 50 mg/kg of body weight). Blood samples were first collected from the inferior vena cava. Mice were then intracardially perfused with icecold PBS and tissues were collected. Mice used to investigate the absolute number of thymic pDC were killed by cervical dislocation. Thymus, spleen and lymph nodes were finely minced and digested with 2 mg/ml of collagenase D (Roche) and 25 µg/ml of DNase I (Roche) in HBSS (Invitrogen) for 1 hour at 37° C under agitation. Supernatants from each digestion were supplemented with 100 mM EDTA (Invitrogen) incubated for 5 min at 37°C, passed through a 70 μm cell strainer (BD Biosciences) and washed in PBS 2% fetal bovine serum (FBS). Red blood cells were lysed in blood samples and spleen cell suspensions using 0.83% NH4Cl. Thymic stromal cells were isolated using Percoll (GE Healthcare; 1.130 g/ml) gradient (densities 1.065 and 1.115) centrifugation (protocol adapted from [9, 19, 20] ). Cells were first incubated with a blocking solution containing anti-Fc receptor (Clone 2.4G; BD Pharmingen) and Syrian hamster IgG (Jackson Immuno Research Laboratories Inc.) in HBSS 2% FBS and 0,01% sodium azide. They were then incubated with fluorochrome or biotin-conjugated antibodies: PercPCy5.5 anti-CD19 (1D3; eBioscience), APC-Cy7 anti-CD3ε (145-2c11; Biolegend), biotin anti-CD11c (HL3; BD Pharmingen), FITC or PE-Cy7 anti-Sirpα (P84; Biolegend), Brillant violet 421 (BV421) anti-B220 (ra3-6b2; BD Horizon TM ), in HBSS 2% FBS and 0,01% sodium azide followed by an incubation with APC fluorochrome-conjugated streptavidin in HBSS 2% FBS and 0,01% sodium azide. Cells were acquired on a LSRII flow cytometer with FACSDiva software version 8.0 (BD Biosciences) and analyzed with FlowLogic (Inivai technologies) Version 6. Analyses were performed using appropriate isotype controls. Experiments were performed three times in total.
2.3. Cell preparation and flow cytometry for progenitor study Seven-week old mice were killed by cervical dislocation. Thymuses were collected and homogenized through a 70 m nylon mesh (BD Falcon TM cell strainer) and washed in PBS 2% FBS. Cells were then stained as previously described with V500 anti-CD4 (RM4-5; BD Horizon), biotin anti-CD8 (53.6-7; BD Pharmingen), APC-Cy7 anti-CD3ε (145-2c11; Biolegend), PE-Cy7 anti-CD25 (pc61; Biolegend), PercPCy5.5 anti-CD44 (IM7; Biolegend), FITC anti-CD24 (m1/69; Biolegend), BV 421 anti-CD117 (2b8; Biolegend) and APC fluorochrome-conjugated streptavidin. Analyses were performed using appropriate isotype controls.
Immunofluorescence
Seven-week old mice were killed by cervical dislocation. Thymuses were removed and snap frozen in CO2 snow. Ten µm thick sections were fixed in 4% PFA, blocked for 1h with PBS, 0.2 % Triton X-100, 3% BSA, stained for 1h with rat anti-mouse PDCA-1 Alexa Fluor® 488 (927; Biolegend) with either purified rabbit anti-mouse keratin 14 (Covance) or purified rabbit anti-mouse laminin (Cedarlane) antibodies and stained for an additional hour with donkey anti-rat IgG A488 (Molecular Probes; Invitrogen) and donkey anti-rabbit IgG A555 antibodies (Molecular Probes; Invitrogen). The sections were counterstained with 4,6-diamidino-2-phenylindole (DAPI, Invitrogen) and mounted with Fluorescence Mounting Medium (Dako). Control sections incubated with an isotype-matched primary antibody (FITC rat IgG2b,κ Biolegend)) or a "negative control rabbit immunoglobulin fraction" (DAKO) showed no staining. The sections were visualized with an Olympus DP71 digital camera mounted on an Olympus BX51 microscope (Olympus) or with Olympus DP80 digital camera mounted on an Olympus BX63 microscope (Olympus). Images were acquired with the Cellsens software (Olympus) and the images were merged using Image J (National Institutes of Health).
Statistics
Data were analyzed with a non-parametric one way ANOVA with Dunn's post test (compare to selected groups) using Prism 4 (GraphPad). P-values <0.05 were considered significant.
Results
Lack of CCR2 perturbs Sirpα DC and pDC homeostasis in the thymus.
To address whether the CCL2-CCR2 axis played a role in pDC migration into the thymus, we investigated the 3 thymic DC subtypes in perfused B6, CCL2 deficient (CCL2KO) and CCR2 red fluorescent protein (RFP)/RFP mice (CCR2 RFP/RFP) which lack CCR2. In CCR2 RFP/RFP mice, proportions ( Figure 1A ) and absolute numbers ( Figure 1B) Figure 1A and 1B). The Sirpα -DC population was not affected in mice deficient in CCL2 or CCR2. These data show a role for CCR2 in homeostasis of thymic pDC and Sirpα + DC. We then investigated the expression of CCR2 by thymic DC, using CCR2 RFP/+ reporter mice. The majority of the pDC and Sirpα + DC expressed high levels of CCR2 while CCR2 expression was more heterogeneous in the Sirpα -DC ( Figure 1C ). Expression of CCR2 by Sirpα -DC ranged from none at all to high levels ( Figure 1C) . We previously showed that CCL2 was expressed in thymus, mainly by endothelial cells but also by cortical and medullary thymic epithelial cells [16] . It has been shown that thymic DC that expressed XCR1 were arrested at the cortico-medullary junction in mice deficient for its ligand, the chemokine XCL1 [11] . We thus addressed whether the lack of CCL2 or CCR2 affected pDC migration within the thymus. pDC were identified using PDCA-1 in lymph nodes of EAE mice [21] . We thus analyzed thymic sections by staining with antibodies specific for PDCA-1 to identify pDC and laminin to visualize vessels. In B6 mice, pDC were observed in the parenchyma ( Figure  1D ) as well as in some cortical and medullary vessels ( Figure 1D and 1E ). Cortex and medulla was defined by DAPI staining ( Figure 1D ). pDC localization in both cortex and medulla was confirmed with sections stained for PDCA-1 and keratin-14 to locate the medulla (data not shown). At higher magnification, pDC could be observed crossing the basal membrane, supporting their circulating ability ( Figure 1E ). We did not observe any differences in pDC localization between B6 and mice deficient for CCL2 or CCR2 ( Figure 1D ). This observation suggests that pDC migration to the cortex or to the medulla is not affected by the lack of CCL2 or CCR2. Taken together, these data suggest that CCR2 is expressed by circulating pDC and Sirpα + DC, and is involved in homeostasis of these cells in the thymus.
Lack of CCR2 perturbs pDC homeostasis in peripheral lymphoid organs and blood
We then addressed whether lack of CCL2 or CCR2 also affected homeostasis of these DC subtypes in blood and peripheral lymphoid tissues. Although the total number of cells as well as the % of CD3 -
CD19
-cells from total did not change between strains, the proportion of pDC was decreased in both lymph nodes ( Figure 2A ) and spleen ( Figure 2B ) in CCR2 RFP/RFP compared to B6 mice and tended to decrease in blood ( Figure 2C ). cDC (CD11c hi B220 -) were reduced in lymph nodes compared to B6 mice (Figure 2A ) but only Sirpα + DC were affected, not Sirpα -DC (Figure 2A ). In spleen, neither cDC ( Figure 2B) nor Sirpα + or Sirpα -DC populations were affected ( Figure 2B ). As expected, we mainly observed CD11c dim cells and only a low frequency of CD11c hi cells in blood [22, 23] compared to the spleen, lymph nodes or thymus ( Figure 2D ). Due to this low CD11c hi cell frequency, cDC were not analyzed in blood. In contrast to CCR2-deficient mice, there was no change in pDC or cDC in CCL2-deficient mice. Taken together these data suggest that CCR2 but not CCL2 is involved in pDC homeostasis. We then investigated CCR2 expression by DC subtypes in blood and peripheral lymphoid organs. CCR2 was highly expressed by pDC in the lymph nodes, spleen and blood ( Figure D-F) as well as by both Sirpα + and Sirpα -DC in lymph nodes ( Figure 2E ). In spleen, cDC displayed a heterogeneous expression of CCR2 reflecting a high expression of CCR2 by Sirpα -DC and a heterogeneous expression by Sirpα + DC, with a high proportion of these cells expressing CCR2 at a dim level ( Figure 2F ). Due to the low CD11c hi cell frequency, CCR2 expression by cDC was not analyzed in blood. These data show that CCR2 is expressed by all pDC and cDC in the periphery.
CCR2 is expressed by thymic progenitors
The origin of thymic DC is not well understood. It has been suggested that they develop extrathymically and migrate to the thymus [13, 24] or alternatively they could arise in the thymus from committed or uncommitted DC precursors [15, [25] [26] [27] 
CD44
+ cell population, also called double negative (DN) 1 population in reference to the first stage of T cell development [28] . We thus investigated whether these progenitors expressed CCR2. We could detect CCR2 in CD4 [15, 25, 28] . CCR2 was clearly and highly expressed by DN1e while it was barely expressed by DN1d (Figure 3 ). Due to the paucity of events recorded for the 2 other DN1 populations, CCR2 expression by these cell populations could not be interpreted and are therefore not shown. This data suggest that DC progenitors may also be recruited in a CCR2-dependent manner.
Discussion
We show that pDC expressed CCR2 at a high level in all lymphoid tissues tested and that their homeostasis was affected by the lack of CCR2 but not by the lack of CCL2. Sirpα + DC and Sirpα -DC display different CCR2 expression, according to the tissue. Sirpα + DC expressed CCR2 at a high level in thymus and lymph nodes, but expression was more heterogeneous in spleen, whereas Sirpα -DC only dimly expressed CCR2 in thymus while they expressed it at a high level in lymph nodes and spleen. Finally we show that at least one subpopulation of DC progenitors expressed high levels of CCR2.
CCR2 was expressed by the three thymic DC subtypes. These data confirm the mRNA expression profile already observed in these three populations [8, 16] and its protein expression by Sirpα + DC [10] . We also showed that CCR2 expression differed according to DC subtypes. Both pDC and Sirpα + DC expressed CCR2 at a high level, supporting their ability to migrate to the thymus [9, 10] , in line with our previous data showing increased numbers of pDC in thymus of transgenic mice that overexpressed CCL2 [16] . Heterogeneous CCR2 expression on splenic and lymph node pDC has been demonstrated by Sawai et al. using anti-CCR2 staining [29] . In contrast, using CCR2 RFP/+ reporter mice, we showed a high expression of CCR2 by the majority of the pDC in spleen, lymph nodes and also in blood. These differences may be explained by the fact that RFP expression reflects membrane, as well as intracellular expression of CCR2, that cannot be detected by extracellular anti-CCR2 staining. In CCR2 RFP/RFP mice that lack functional CCR2, we observed a decrease in proportion of pDC in thymus but also in spleen, lymph nodes and blood. Although not significant, pDC proportions in blood also tended to decrease, as opposed to the increase that would be expected if CCR2 was involved only in pDC recruitment to tissues [9] . All together these data point to a role for CCR2 in pDC homeostasis. This observation is in line with the role of CCR2 in monocyte [30, 31] or Sirpα + DC [10] release from bone marrow to blood.
We previously showed a higher proportion of pDC in thymus overexpressing CCL2 [16] . However we did not observe here any role for CCL2 in pDC homeostasis. The chemokine-chemokine receptor system is redundant, and other CCR2 ligands could play a role in pDC homeostasis, such that deletion of only one chemokine would not be enough to see any effect. The chemokines CCL7, CCL8 and CCL12 are also ligands for CCR2 (see review [14] ), and CCL2 and CCL8 have been detected in thymus [10, 16] . Some chemokines and chemokine receptors have been implicated in DC migration within the thymus [10, 11] , however our data do not suggest a major role for either CCR2 or CCL2 in pDC migration through the basal membrane or within the thymus.
In our previous study, mice that overexpressed CCL2 in thymus generated reduced numbers of autoreactive T cells [16] . One might predict on this basis that mice deficient for CCL2 or CCR2 would have increased frequencies of autoreactive T cells and perhaps be more susceptible to autoimmune disease. However such mice are reported to be resistant to EAE or to develop mild disease [32] [33] [34] . The CCL2-CCR2 axis was shown to be involved in recruitment of monocytes or macrophages that are required for the Th1 immune response in EAE. It can be speculated that CCR2 plays a role in homeostasis in both normophysiology and pathology, while CCL2 is mainly involved in pathology.
The ability of precursors or progenitors to differentiate to pDC is debated. Thymic CD4 low precursors or early T-cell progenitors, or DN1d and DN1e cells, migrated to the thymus after intravenous injection and differentiated to CD11c DC [15, 27] . More specifically, intravenously injected macrophage-DC progenitors, common DC precursors, and pre-DC developed into CD8α + DC once in the thymus [25] . One study showed that pre-DC (Lin - 
CD11c
+ MHC class II − SIRP-α int Flt3 + cells) did not give rise to pDC [35] but a recent study showed that these pre-DC population can be subdivided into different subpopulations based on Siglec-H and Ly6C expression and that the Siglec-H + Ly6C -pre-DC had the potential to differentiate to pDC [36] . Another study showed that the DN1d subset had a similar gene profile to thymic pDCs [15] suggesting that DN1d could give rise to pDC. We showed that the DN1e subset expressed CCR2 but that DN1d cells did not. The decrease of pDC observed in thymus is thus not likely to be due to a decrease in recruitment of DN1d progenitors. Little is known about the lineage potential of the DN1e subpopulation. The fact that they highly expressed CCR2 suggests that this population might be recruited into the thymus in a CCR2-dependent manner and also might differentiate to pDC.
In conclusion our study shows that CCR2 plays a role in homeostasis of pDC. CCL2, its major ligand, does not play a significant role in this process, pointing to (an) involvement of other CCR2 ligand(s). We also show that CCR2 was expressed on some DC progenitors in thymus, raising the possibility of a role for CCR2 in their homeostasis.
(scale bars: 100 µm). Micrographs are representative from two individual mice per group. At higher magnification, pDC were observed crossing a vessel (scale bar: 5µm) (E). 
